Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Abstract In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response...
Saved in:
Main Authors: | Yang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, Cheng-Hsiang Lo, Jen-Fu Yang, Chun-Shu Lin, Hsing-Lung Chao, Wen-Yen Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4214af13ccb94d3a95aa527a65bc27ae |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of Radiosensitizers in Cancer Radiotherapy
by: Gong L, et al.
Published: (2021) -
Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects
by: Yang S, et al.
Published: (2021) -
Novel emerging biomarkers to immunotherapy in kidney cancer
by: Yasser Ged, et al.
Published: (2021) -
Mutation load estimation model as a predictor of the response to cancer immunotherapy
by: Guan-Yi Lyu, et al.
Published: (2018) -
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
by: Wu M, et al.
Published: (2018)